Sensus Healthcare, Inc. (SRTS) Cash Flow Statement
Where SRTS’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- $528,000
- Capital expenditures
- $196,000 0.7% of revenue
- Free cash flow
- $332,000 1.2% margin
- Returned to shareholders
- $300,000 90% of free cash flow
- Change in cash
- $27,000 cash at year-end $22.1M
Drawn to scale: where the cash came from and how it was used. Hover for values.
SRTS operating cash flow, capex and free cash flow
SRTS cash flow trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$851,0242016 | $528,0002025 | — | |
| Capital expenditures | $285,9982016 | $196,0002025 | −4.1%/yr | |
| Free cash flow | −$1.1M2016 | $332,0002025 | — | |
| Free cash flow margin | −7.7%2016 | 1.2%2025 | +8.9 pts | |
| Operating cash flow / net income | −0.072021 | −0.132024 | −0.06 | |
| Stock-based compensation | $726,3772016 | $295,0002025 | −9.5%/yr | |
| Dividends paid | $2.6M2016 | $731,0002022 | −18.8%/yr | |
| Share buybacks (net) | $02016 | $300,0002025 | — | |
| Capex / revenue | 1.9%2016 | 0.7%2025 | −1.2 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SRTS cash flow by activity
SRTS net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
SRTS cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$7.7M | $6.6M | $485,000 | $24.2M | $4.1M | −$6.8M | −$1.7M | −$2.0M | −$3.7M | −$346,448 |
| Depreciation & amortization | $626,000 | $432,000 | $461,000 | $509,000 | $613,000 | $722,000 | $545,717 | $658,255 | $387,917 | $337,583 |
| Stock-based compensation | $295,000 | $323,000 | $328,000 | $187,000 | $415,000 | $386,000 | $620,925 | $982,624 | $405,896 | $726,377 |
| Change in working capital | $8.7M | −$8.6M | −$3.6M | −$12.9M | −$6.1M | $5.6M | −$2.3M | −$8.3M | −$568,857 | −$4.6M |
| Other non-cash items | −$1.3M | $321,000 | $141,000 | −$13.4M | $705,000 | −$267,928 | $728,915 | $108,527 | $428,952 | $3.0M |
| Cash from operating activities | $528,000 | −$831,000 | −$2.1M | −$1.4M | −$286,000 | −$434,180 | −$2.1M | −$8.6M | −$3.1M | −$851,024 |
| Investing activities | ||||||||||
| Capital expenditures | −$196,000 | −$276,000 | −$229,000 | −$159,000 | −$128,000 | −$358,540 | −$400,588 | −$854,834 | −$287,594 | −$285,998 |
| Investments (net) | — | −$276,000 | −$197,000 | $14.8M | $129,000 | $7.4M | −$4.5M | −$1.8M | $6.2M | −$7.9M |
| Acquisitions & other investing | $0 | $276,000 | $239,000 | $159,000 | $128,000 | −$5 | −$5 | $0 | $287,594 | $285,998 |
| Cash from investing activities | −$196,000 | −$276,000 | −$187,000 | $14.8M | $129,000 | $7.0M | −$4.9M | −$2.6M | $6.2M | −$7.9M |
| Financing activities | ||||||||||
| Dividends paid | — | — | — | −$731,000 | — | −$210,337 | — | — | $0 | −$2.6M |
| Share repurchases & issuance (net) | −$300,000 | −$52,000 | −$27,000 | −$3.0M | −$15,000 | −$57,000 | −$118,754 | −$118,648 | −$289,286 | $13.8M |
| Net borrowing (repayment) | — | — | $0 | −$51,000 | −$216,000 | $266,777 | $266,777 | −$2.2M | $2.2M | −$422,702 |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $17.2M | $0 | $0 |
| Other financing | −$5,000 | $67,000 | −$13,000 | $1.4M | $0 | $210,566 | $2.5M | −$1.3M | $0 | −$2.1M |
| Cash from financing activities | −$305,000 | $15,000 | −$40,000 | −$2.4M | −$231,000 | $210,006 | $2.6M | $13.6M | $1.9M | $8.7M |
| Summary | ||||||||||
| Net change in cash | $27,000 | −$1.1M | −$2.4M | $11.0M | −$388,000 | $6.8M | −$4.4M | $2.4M | $5.0M | −$22,591 |
| Cash at end of period | $22.1M | $22.1M | $23.1M | $25.5M | $14.5M | $14.9M | $8.1M | $12.5M | $10.1M | $5.0M |
| Free cash flow | $332,000 | −$1.1M | −$2.4M | −$1.6M | −$414,000 | −$792,720 | −$2.5M | −$9.4M | −$3.3M | −$1.1M |
| Free cash flow margin | 1.2% | −2.6% | −9.7% | −3.5% | −1.5% | −8.3% | −9.2% | −35.6% | −16.2% | −7.7% |
| Capex / revenue | 0.7% | 0.7% | 0.9% | 0.4% | 0.5% | 3.7% | 1.5% | 3.2% | 1.4% | 1.9% |
| Operating cash flow / net income | — | −0.13 | −4.42 | −0.06 | −0.07 | — | — | — | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$8.7M | −$2.6M | −$3.2M | −$943,000 | −$1.0M | −$2.6M | $1.5M | $1.2M | $1.6M | $2.3M | $4.2M | −$1.5M |
| Depreciation & amortization | $147,000 | $158,000 | $164,000 | $159,000 | $158,000 | $145,000 | $134,000 | $102,000 | $78,000 | $118,000 | $106,000 | $106,000 |
| Stock-based compensation | $70,000 | $70,000 | $76,000 | $73,000 | $67,000 | $79,000 | $122,000 | $45,000 | $65,000 | $91,000 | $52,000 | $67,000 |
| Change in working capital | −$343,000 | $174,000 | $465,000 | $4.1M | $4.6M | −$484,000 | −$2.8M | $3.2M | $2.7M | −$11.6M | −$3.0M | $1.8M |
| Other non-cash items | $5.7M | −$1.5M | $255,000 | −$1.1M | −$630,000 | $155,000 | $174,000 | −$577,000 | −$253,000 | $977,000 | $1.3M | −$121,000 |
| Cash from operating activities | −$3.1M | −$3.8M | −$2.2M | $2.3M | $3.1M | −$2.7M | −$827,000 | $4.0M | $4.2M | −$8.2M | $2.7M | $442,000 |
| Investing activities | ||||||||||||
| Capital expenditures | −$3,000 | −$3,000 | −$158,000 | −$4,000 | −$27,000 | −$7,000 | −$297,000 | −$337,000 | −$3,000 | −$233,000 | −$229,000 | −$11,000 |
| Investments (net) | — | — | — | −$4,000 | −$27,000 | −$7,000 | $297,000 | −$337,000 | −$3,000 | −$233,000 | $0 | $31,000 |
| Acquisitions & other investing | −$5,000 | $0 | $0 | $4,000 | $27,000 | $7,000 | $297,000 | $337,000 | $3,000 | $233,000 | $416,000 | $11,000 |
| Cash from investing activities | −$8,000 | −$3,000 | −$158,000 | −$4,000 | −$27,000 | −$7,000 | $297,000 | −$337,000 | −$3,000 | −$233,000 | $187,000 | $31,000 |
| Financing activities | ||||||||||||
| Share repurchases & issuance (net) | $0 | $0 | $0 | $0 | $0 | −$300,000 | $0 | −$47,000 | $0 | $0 | −$7,000 | −$27,000 |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | $0 | $0 | −$5,000 | $0 | $0 | $0 | $28,000 | $17,000 | $17,000 | $0 | $0 | −$12,000 |
| Cash from financing activities | $0 | $0 | −$5,000 | $0 | $0 | −$300,000 | $28,000 | −$30,000 | $17,000 | $0 | −$7,000 | −$39,000 |
| Summary | ||||||||||||
| Net change in cash | −$3.1M | −$3.8M | −$2.4M | $2.3M | $3.1M | −$3.0M | −$502,000 | $3.6M | $4.2M | −$8.4M | $2.7M | $434,000 |
| Cash at end of period | $15.2M | $18.3M | $22.1M | $24.5M | $22.2M | $19.1M | $22.1M | $22.6M | $19.0M | $14.7M | $23.1M | $20.5M |
| Free cash flow | −$3.1M | −$3.8M | −$2.4M | $2.3M | $3.1M | −$2.7M | −$530,000 | $3.6M | $4.2M | −$8.4M | $2.7M | $431,000 |
| Free cash flow margin | −136.7% | −110.7% | −47.9% | 33.3% | 42.2% | −32.2% | −4.1% | 40.9% | 45.8% | −79.0% | 21.2% | 11.1% |
| Capex / revenue | 0.1% | 0.1% | 3.2% | 0.1% | 0.4% | 0.1% | 2.3% | 3.8% | 0.0% | 2.2% | 1.8% | 0.3% |
| Operating cash flow / net income | — | — | — | — | — | — | −0.53 | 3.25 | 2.62 | −3.60 | 0.63 | — |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
SRTS cash generation
In fiscal 2025 (ended December 31, 2025), Sensus Healthcare generated $0.5 million of cash from operations and spent $0.2 million on capital expenditures, leaving free cash flow of $0.3 million, 1.2% of revenue. It returned $0.3 million to shareholders through dividends ($0) and net share buybacks ($0.3 million). Cash and equivalents rose by $0.0 million over the year.
Related: SRTS income statement, SRTS balance sheet. See the SRTS stock overview for the latest quote and news.
SRTS cash flow FAQ
What is Sensus Healthcare's free cash flow?
Sensus Healthcare's free cash flow was $0.3 million in fiscal 2025: $0.5 million of operating cash flow minus $0.2 million of capital expenditures It was -$1.1 million a year earlier..
How much cash does Sensus Healthcare generate from operations?
Sensus Healthcare generated $0.5 million of cash from operating activities in fiscal 2025.
How much does Sensus Healthcare spend on capital expenditures?
Sensus Healthcare spent $0.2 million on capital expenditures in fiscal 2025, 0.7% of revenue, compared with $0.3 million the year before.
How much stock does Sensus Healthcare buy back?
Sensus Healthcare spent $0.3 million on net share repurchases in fiscal 2025.